CSL Limited (ASX:CSL)’s share price crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.00 and traded as low as $228.90. CSL shares last traded at $228.90, with a volume of 549,321 shares trading hands.
The company has a debt-to-equity ratio of 95.80, a current ratio of 2.93 and a quick ratio of 1.46. The stock has a market cap of $104.92 billion and a PE ratio of 58.32. The stock’s 50-day moving average price is A$220.21.
CSL Company Profile (ASX:CSL)
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders.
See Also: Stop Order
Receive News & Ratings for CSL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSL and related companies with MarketBeat.com's FREE daily email newsletter.